Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

11.07.2022

1 Ann Intern Med
3 Anticancer Res
3 Biochem Biophys Res Commun
2 BMC Cancer
4 BMC Gastroenterol
1 Cancer
2 Cancer Res
2 Dig Dis
3 Dig Dis Sci
1 Endoscopy
1 Eur Radiol
1 Gastroenterology
2 Gut
4 Hepatology
1 Int J Cancer
2 J Gastroenterol
1 J Gastroenterol Hepatol
2 J Hepatol
1 Oncogene
3 PLoS One



    Ann Intern Med

  1. KORETZ RL
    Aspirin use is associated with reduced risk for hepatocellular carcinoma.
    Ann Intern Med. 2022 Jul 5. doi: 10.7326/J22-0049.
    >> Share


    Anticancer Res

  2. HUDSON JM, Singh S, Milot L, Patel C, et al
    Dynamic Contrast-enhanced CT to Evaluate Early Response in Neuroendocrine Liver Metastases Treated With Everolimus and Radiation.
    Anticancer Res. 2022;42:3523-3527.
    >> Share

  3. NAKASEKO Y, Furukawa K, Haruki K, Onda S, et al
    Standardized and Feasible Laparoscopic Approach for Tumors Located in the Caudate Lobe.
    Anticancer Res. 2022;42:3621-3625.
    >> Share

  4. KANG BY, Kim SM, Hur W, Roh PR, et al
    Enhanced Tumoricidal Immune Responses by Transarterial Chemotherapy Using Novel Nanocomplexes in a Rat Liver Cancer Model.
    Anticancer Res. 2022;42:3463-3473.
    >> Share


    Biochem Biophys Res Commun

  5. MENG J, Zhang C, Wang D, Zhu L, et al
    Mitochondrial GCN5L1 regulates cytosolic redox state and hepatic gluconeogenesis via glycerol phosphate shuttle GPD2.
    Biochem Biophys Res Commun. 2022;621:1-7.
    >> Share

  6. CHU K, Zhao N, Hu X, Feng R, et al
    LncNONMMUG027912 alleviates lipid accumulation through AMPKalpha/mTOR/SREBP1C axis in nonalcoholic fatty liver.
    Biochem Biophys Res Commun. 2022;618:8-14.
    >> Share

  7. CAI Q, Zhu J, Cui X, Xia Y, et al
    S100A9 promotes inflammatory response in diabetic nonalcoholic fatty liver disease.
    Biochem Biophys Res Commun. 2022;618:127-132.
    >> Share


    BMC Cancer

  8. ZHAO W, Guo J, Li H, Cai L, et al
    Retraction Note: FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells.
    BMC Cancer. 2022;22:733.
    >> Share

  9. XIAO LS, Li RN, Cui H, Hong C, et al
    Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study.
    BMC Cancer. 2022;22:737.
    >> Share


    BMC Gastroenterol

  10. MA B, Shang T, Huang J, Tu Z, et al
    Analysis of clinical features and prognostic factors in patients with hepatic hydrothorax: a single-center study from China.
    BMC Gastroenterol. 2022;22:333.
    >> Share

  11. ABEYSEKERA KWM, Orr JG, Gordon FH, Howe LD, et al
    Evaluating future risk of NAFLD in adolescents: a prediction and decision curve analysis.
    BMC Gastroenterol. 2022;22:323.
    >> Share

  12. ALONSO JC, Casans I, Gonzalez FM, Fuster D, et al
    Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review.
    BMC Gastroenterol. 2022;22:326.
    >> Share

  13. CAO G, Wang X, Chen H, Gao S, et al
    Hepatic arterial infusion chemotherapy plus regorafenib in advanced colorectal cancer: a real-world retrospective study.
    BMC Gastroenterol. 2022;22:328.
    >> Share


    Cancer

  14. PARIKH ND, Mehta N, Hoteit MA, Yang JD, et al
    Association between sustained virological response and clinical outcomes in patients with hepatitis C infection and hepatocellular carcinoma.
    Cancer. 2022 Jul 7. doi: 10.1002/cncr.34378.
    >> Share


    Cancer Res

  15. XIE C, Wang FY, Sang Y, Chen B, et al
    Mitochondrial Micropeptide STMP1 Enhances Mitochondrial Fission to Promote Tumor Metastasis.
    Cancer Res. 2022;82:2431-2443.
    >> Share

  16. WANG JC, Chen DP, Lu SX, Chen JB, et al
    PIM2 expression induced by proinflammatory macrophages suppresses immunotherapy efficacy in hepatocellular carcinoma.
    Cancer Res. 2022 Jul 11. pii: 706923. doi: 10.1158/0008-5472.CAN-21-3899.
    >> Share


    Dig Dis

  17. GISZAS B, Weber M, Heidel FH, Reuken PA, et al
    Recurrent Upper Gastrointestinal Bleeding from Isolated Gastric Varices as Primary Symptom of Myelofibrosis: A Case Report on Combining Interventional and Pharmacologic Treatment Options.
    Dig Dis. 2022;40:530-534.
    >> Share

  18. JUNGST C, Justinger C, Fischer J, Berg T, et al
    Common ABCB4 and ABCB11 genotypes are associated with idiopathic chronic cholestasis in adults.
    Dig Dis. 2021 Jul 6. pii: 000518203. doi: 10.1159/000518203.
    >> Share


    Dig Dis Sci

  19. YARRA P, Dunn W, Younossi Z, Kuo YF, et al
    Association of Previous Gastric Bypass Surgery and Patient Outcomes in Alcohol-Associated Cirrhosis Hospitalizations.
    Dig Dis Sci. 2022 Jul 4. pii: 10.1007/s10620-022-07591.
    >> Share

  20. IZZY M, VanWagner LB
    Analyzing the Different Prevalence for Cirrhotic Cardiomyopathy in Different Studies.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07580.
    >> Share

  21. NATARAJAN Y, Patel P, Chu J, Yu X, et al
    Risk of Hepatocellular Carcinoma in Patients with Various HFE Genotypes.
    Dig Dis Sci. 2022 Jul 5. pii: 10.1007/s10620-022-07602.
    >> Share


    Endoscopy

  22. TOYONAGA H, Hayashi T, Kin T, Hama K, et al
    Combination of ERCP with endoscopic ultrasound-guided hepaticogastrostomy and hepaticoduodenostomy for biliary drainage in malignant hilar biliary obstruction.
    Endoscopy. 2022 Jul 1. doi: 10.1055/a-1864-9339.
    >> Share


    Eur Radiol

  23. ZHU HD, Li X, Ji JS, Huang M, et al
    TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
    Eur Radiol. 2022 Jul 1. pii: 10.1007/s00330-022-08848.
    >> Share


    Gastroenterology

  24. KIM NJ, Vutien P, Berry K, Ioannou GN, et al
    Hepatocellular carcinoma risk declines but remains high enough for screening in the first 7 years after HCV cure with DAAs in patients with cirrhosis or high FIB-4.
    Gastroenterology. 2022 Jun 28. pii: S0016-5085(22)00681.
    >> Share


    Gut


  25. Correction: Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19.
    Gut. 2022;71:e9.
    >> Share

  26. BUCH S, Innes H, Lutz PL, Nischalke HD, et al
    Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
    Gut. 2022 Jul 4. pii: gutjnl-2022-327196. doi: 10.1136/gutjnl-2022-327196.
    >> Share


    Hepatology

  27. SCHMID CD, Olsavszky V, Reinhart M, Weyer V, et al
    ALK1 controls hepatic vessel formation, angiodiversity, and angiocrine functions in hereditary hemorrhagic telangiectasia of the liver.
    Hepatology. 2022 Jul 1. doi: 10.1002/hep.32641.
    >> Share

  28. FAN Y, Jiang ST, Yong-Chang Z
    Letter to the Editor: Some reflection on the research related to METTL1 promoting radiotherapy resistance in hepatocellular carcinoma.
    Hepatology. 2022 Jul 1. doi: 10.1002/hep.32644.
    >> Share

  29. KOVALIC AJ, Lee TP, Da BL
    Letter to the editor: L-ornithine L-aspartate in acute treatment of severe hepatic encephalopathy: A double-blind randomized controlled trial.
    Hepatology. 2022 Jul 5. doi: 10.1002/hep.32643.
    >> Share

  30. ZHANG Y, Ye S, Lu W, Zhong J, et al
    RNA helicase DEAD-box protein 5 alleviates nonalcoholic steatohepatitis progression via tethering TSC complex and suppressing mTORC1 signaling.
    Hepatology. 2022 Jul 7. doi: 10.1002/hep.32651.
    >> Share


    Int J Cancer

  31. FU P, Gong B, Li H, Luo Q, et al
    Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus-related hepatocellular carcinoma.
    Int J Cancer. 2022 Jul 8. doi: 10.1002/ijc.34201.
    >> Share


    J Gastroenterol

  32. LIU T, Liao S, Mo J, Bai X, et al
    LncRNA n339260 functions in hepatocellular carcinoma progression via regulation of miRNA30e-5p/TP53INP1 expression.
    J Gastroenterol. 2022 Jul 8. pii: 10.1007/s00535-022-01901.
    >> Share

  33. OKUSHIN K, Tateishi R, Takahashi A, Uchino K, et al
    Current status of primary liver cancer and decompensated cirrhosis in Japan: launch of a nationwide registry for advanced liver diseases (REAL).
    J Gastroenterol. 2022 Jul 5. pii: 10.1007/s00535-022-01893.
    >> Share


    J Gastroenterol Hepatol

  34. UFUK F, Aykota MR
    Hepatobiliary and Pancreatic: Todani type I choledochal cyst and cystic malformation of the cystic duct.
    J Gastroenterol Hepatol. 2022 Jul 6. doi: 10.1111/jgh.15931.
    >> Share


    J Hepatol

  35. FONTANELLAS A, Avila MA
    Hydroxymethylbilane synthase (aka porphobilinogen deaminase): a novel metabolic tumor suppressor gene in hepatocellular carcinoma.
    J Hepatol. 2022 Jul 4. pii: S0168-8278(22)02921.
    >> Share

  36. VERMA AK, Sharma A, Subramaniyam N, Gandhi CR, et al
    Augmenter of liver regeneration: mitochondrial function and steatohepatitis.
    J Hepatol. 2022 Jun 28. pii: S0168-8278(22)00413.
    >> Share


    Oncogene

  37. PAN D, Yang W, Zeng Y, Qin H, et al
    AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma.
    Oncogene. 2022 Jun 30. pii: 10.1038/s41388-022-02379.
    >> Share


    PLoS One

  38. HUANG YJ, Wang PM, Tang KS, Chen CJ, et al
    Butyrate ameliorates maternal high-fat diet-induced fetal liver cellular apoptosis.
    PLoS One. 2022;17:e0270657.
    >> Share

  39. ZUO Z, Cui H, Wang M, Huang C, et al
    Diagnostic of FibroTouch and six serological models in assessing the degree of liver fibrosis among patients with chronic hepatic disease: A single-center retrospective study.
    PLoS One. 2022;17:e0270512.
    >> Share

  40. NAKAI M, Suda G, Ogawa K, Yoshida S, et al
    Efficacy of rifaximin against covert hepatic encephalopathy and hyperammonemia in Japanese patients.
    PLoS One. 2022;17:e0270786.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016